Amedisys, Inc. (AMED) Tops Q4 EPS by 2c; Guides FY13

March 12, 2013 7:10 AM

Amedisys, Inc. (NASDAQ: AMED) reported Q4 EPS of $0.24, $0.02 better than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found